gabapentin has been researched along with Canine Diseases in 17 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess whether there is a change in seizure activity in dogs with refractory epilepsy that are receiving appropriate doses of phenobarbitone and/or potassium bromide, when gabapentin is added to the therapeutic regimen." | 7.73 | Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent. ( Govendir, M; Malik, R; Perkins, M, 2005) |
| "To assess whether there is a change in seizure activity in dogs with refractory epilepsy that are receiving appropriate doses of phenobarbitone and/or potassium bromide, when gabapentin is added to the therapeutic regimen." | 3.73 | Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent. ( Govendir, M; Malik, R; Perkins, M, 2005) |
| "This severe pain is mostly refractory to palliative analgesic treatment, and the latter was only detected by specific and sensitive outcomes." | 2.87 | Pain characterization and response to palliative care in dogs with naturally-occurring appendicular osteosarcoma: An open label clinical trial. ( Beauchamp, G; Blair, J; de Lorimier, LP; Lussier, B; Monteiro, BP; Moreau, M; Pelletier, JP; Troncy, E, 2018) |
| " Other gabapentin doses or dosing regimens warrant further study." | 2.75 | Clinical evaluation of perioperative administration of gabapentin as an adjunct for postoperative analgesia in dogs undergoing amputation of a forelimb. ( Hellyer, PW; Mich, PM; Uhrig, SR; Wagner, AE, 2010) |
| "Successful treatment of seizure disorders in small animals requires proper patient assessment, understanding the principles of antiepileptic drug (AED) therapy, designing a strategy for pharmacotherapy, and plans for emergency treatment." | 2.40 | Antiepileptic drug therapy. ( Podell, M, 1998) |
| "Canine neuropathic pain (NeuP) has been poorly investigated." | 1.56 | Pain burden, sensory profile and inflammatory cytokines of dogs with naturally-occurring neuropathic pain treated with gabapentin alone or with meloxicam. ( Auger, JP; Beauchamp, G; Evangelista, MC; Ruel, HLM; Segura, M; Steagall, PV; Watanabe, R, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 12 (70.59) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Erickson, A | 1 |
| Harbin, K | 1 |
| MacPherson, J | 1 |
| Rundle, K | 1 |
| Overall, KL | 1 |
| Ruel, HLM | 1 |
| Watanabe, R | 1 |
| Evangelista, MC | 1 |
| Beauchamp, G | 2 |
| Auger, JP | 1 |
| Segura, M | 1 |
| Steagall, PV | 1 |
| Mauler, DA | 1 |
| De Decker, S | 1 |
| De Risio, L | 1 |
| Volk, HA | 3 |
| Dennis, R | 1 |
| Gielen, I | 1 |
| Van der Vekens, E | 1 |
| Goethals, K | 1 |
| Van Ham, L | 1 |
| Orlando, JM | 2 |
| Monteiro, BP | 1 |
| de Lorimier, LP | 1 |
| Moreau, M | 1 |
| Blair, J | 1 |
| Lussier, B | 1 |
| Pelletier, JP | 1 |
| Troncy, E | 1 |
| Denenberg, S | 1 |
| Plessas, IN | 2 |
| Rusbridge, C | 2 |
| Vanhaesebrouck, AE | 1 |
| Jeffery, ND | 1 |
| Jang, HY | 1 |
| Parent, JM | 1 |
| Hagen, C | 1 |
| Colwell, E | 1 |
| Rist, PM | 1 |
| Murphy, N | 1 |
| Burton, S | 1 |
| Conboy, G | 1 |
| Wolfe, KC | 1 |
| Poma, R | 1 |
| Wagner, AE | 1 |
| Mich, PM | 1 |
| Uhrig, SR | 1 |
| Hellyer, PW | 1 |
| Bain, MJ | 1 |
| Fan, CM | 1 |
| Aghighi, SA | 1 |
| Tipold, A | 1 |
| Piechotta, M | 1 |
| Lewczuk, P | 1 |
| Kästner, SB | 1 |
| Driver, CJ | 1 |
| Chandler, KE | 1 |
| Craig, A | 1 |
| McGonnell, IM | 1 |
| Brodbelt, DC | 1 |
| Govendir, M | 1 |
| Perkins, M | 1 |
| Malik, R | 1 |
| Platt, SR | 1 |
| De Stefani, A | 1 |
| Wieczorek, L | 1 |
| Podell, M | 1 |
2 reviews available for gabapentin and Canine Diseases
| Article | Year |
|---|---|
A review of pre-appointment medications to reduce fear and anxiety in dogs and cats at veterinary visits.
Topics: Animals; Anxiety; Cat Diseases; Cats; Dog Diseases; Dogs; Fear; Gabapentin | 2021 |
Antiepileptic drug therapy.
Topics: Acetates; Amines; Animals; Anticonvulsants; Bromides; Cat Diseases; Cats; Cyclohexanecarboxylic Acid | 1998 |
4 trials available for gabapentin and Canine Diseases
| Article | Year |
|---|---|
Pain characterization and response to palliative care in dogs with naturally-occurring appendicular osteosarcoma: An open label clinical trial.
Topics: Amitriptyline; Analgesics; Animals; Bone Neoplasms; Central Nervous System Sensitization; Dog Diseas | 2018 |
Comparison of gabapentin versus topiramate on clinically affected dogs with Chiari-like malformation and syringomyelia.
Topics: Amines; Analgesics; Animals; Arnold-Chiari Malformation; Cross-Over Studies; Cyclohexanecarboxylic A | 2015 |
Clinical evaluation of perioperative administration of gabapentin as an adjunct for postoperative analgesia in dogs undergoing amputation of a forelimb.
Topics: Amines; Amputation, Surgical; Analgesics; Animals; Cyclohexanecarboxylic Acids; Dog Diseases; Dogs; | 2010 |
Assessment of the effects of adjunctive gabapentin on postoperative pain after intervertebral disc surgery in dogs.
Topics: Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Dog Diseases; Dogs; Female; Gabapentin; ga | 2012 |
11 other studies available for gabapentin and Canine Diseases
| Article | Year |
|---|---|
Pain burden, sensory profile and inflammatory cytokines of dogs with naturally-occurring neuropathic pain treated with gabapentin alone or with meloxicam.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Cytokines; Dog Diseases; Dogs; Fe | 2020 |
Spinal Arachnoid Diverticula: Outcome in 96 Medically or Surgically Treated Dogs.
Topics: Amines; Animals; Arachnoid Cysts; Carbazoles; Cyclohexanecarboxylic Acids; Dog Diseases; Dogs; Femal | 2017 |
Animal Behavior Case of the Month.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Behavior, Animal | 2017 |
Animal Behavior Case of the Month.
Topics: Animals; Anti-Anxiety Agents; Behavior Therapy; Behavior, Animal; Compulsive Behavior; Dog Diseases; | 2018 |
Animal behavior case of the month. Tail chasing in a dog diagnosed as compulsive disorder.
Topics: Amines; Animals; Anticonvulsants; Behavior, Animal; Bites and Stings; Cyclohexanecarboxylic Acids; D | 2015 |
Paradoxical vestibular syndrome in a dog from western Newfoundland infected with French heartworm
Topics: Amines; Analgesics; Angiostrongylus; Animals; Anthelmintics; Cyclohexanecarboxylic Acids; Dexamethas | 2016 |
Syringomyelia in the Cavalier King Charles spaniel (CKCS) dog.
Topics: Amines; Analgesics; Animals; Anti-Inflammatory Agents; Arnold-Chiari Malformation; Breeding; Cyclohe | 2010 |
Animal behavior case of the month. Motivation for the tail-chasing behavior was considered to most likely be multifactorial.
Topics: Acepromazine; Amines; Animals; Anticonvulsants; Behavior, Animal; Compulsive Behavior; Cyclohexaneca | 2012 |
Long-term outcome of Cavalier King Charles spaniel dogs with clinical signs associated with Chiari-like malformation and syringomyelia.
Topics: Amines; Analgesics; Animals; Arnold-Chiari Malformation; Breeding; Carbazoles; Cohort Studies; Cyclo | 2012 |
Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent.
Topics: Amines; Animals; Anticonvulsants; Bromides; Chemotherapy, Adjuvant; Cyclohexanecarboxylic Acids; Dog | 2005 |
Primary orthostatic tremor in a Scottish deerhound.
Topics: Amines; Animals; Cyclohexanecarboxylic Acids; Dog Diseases; Dogs; Electromyography; Excitatory Amino | 2006 |